Balaji Amines Limited (IN:BALAMINES)
:BALAMINES
Want to see IN:BALAMINES full AI Analyst Report?
Top Page
Balaji Amines Limited
(BALAMINES)
Select Model
Select Model
Rating:69Neutral
Price Target:
₹1,140.00
▲(4.51% Upside)
Action:ReiteratedDate:01/09/26
The score is driven primarily by strong financial quality (low leverage and positive free cash flow), partially offset by mixed technicals (negative MACD and below longer-term moving averages) and a middling valuation (P/E 27.17 with a low ~0.90% dividend yield).
Positive Factors
Strong balance sheet / low leverage
A low debt-to-equity profile and robust equity ratio provide durable financial flexibility. This conservatism supports capital expenditure, working capital needs, and downturn absorption without compromising operations or forcing distress asset sales over the next several quarters.
Negative Factors
Recent revenue and EPS contraction
Declining revenue and materially lower EPS indicate weakening demand or pricing pressure. If this trend persists it could constrain reinvestment, reduce operating leverage benefits, and pressure margins and cash generation over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet / low leverage
A low debt-to-equity profile and robust equity ratio provide durable financial flexibility. This conservatism supports capital expenditure, working capital needs, and downturn absorption without compromising operations or forcing distress asset sales over the next several quarters.
Read all positive factors
Balaji Amines Limited (BALAMINES) vs. iShares MSCI India ETF (INDA)
Market Cap
₹40.51B
Dividend Yield0.97%
Average Volume (3M)3.13K
Price to Earnings (P/E)29.5
Beta (1Y)1.01
Revenue Growth-5.17%
EPS Growth-22.34%
CountryIN
Employees1,084
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)9.70
Shares Outstanding32,401,000
10 Day Avg. Volume2,179
30 Day Avg. Volume3,132
Financial Highlights & Ratios
PEG Ratio-1.11
Price to Book (P/B)2.20
Price to Sales (P/S)2.91
P/FCF Ratio46.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)56.5
Revenue Forecast (FY)₹15.75B
Balaji Amines Limited Business Overview & Revenue Model
Company Description
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and C...
How the Company Makes Money
Balaji Amines primarily makes money by manufacturing and selling chemicals (mainly aliphatic amines and their derivatives) to industrial customers. Revenue is generated through (1) sale of core amines (commodity-to-specialty intermediates) where v...
Balaji Amines Limited Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
82
Very Positive
Cash Flow
79
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.64B | 13.97B | 16.08B | 23.38B | 23.20B | 13.11B |
| Gross Profit | 5.56B | 4.88B | 3.50B | 8.39B | 8.57B | 5.39B |
| EBITDA | 2.52B | 2.65B | 3.53B | 6.24B | 6.36B | 3.79B |
| Net Income | 1.46B | 1.58B | 2.05B | 3.26B | 3.68B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 23.31B | 22.52B | 21.46B | 19.63B | 18.75B | 13.10B |
| Cash, Cash Equivalents and Short-Term Investments | 1.86B | 3.50B | 3.31B | 3.09B | 515.37M | 173.23M |
| Total Debt | 314.46M | 110.27M | 196.97M | 575.74M | 1.01B | 1.27B |
| Total Liabilities | 2.75B | 2.34B | 2.53B | 2.65B | 5.60B | 4.00B |
| Stockholders Equity | 18.82B | 18.45B | 17.22B | 15.54B | 12.50B | 8.94B |
Cash Flow | ||||||
| Free Cash Flow | -1.62B | 874.82M | 704.14M | 2.62B | 842.07M | -221.07M |
| Operating Cash Flow | 222.05M | 2.73B | 3.34B | 3.82B | 2.32B | 1.10B |
| Investing Cash Flow | -1.15B | -1.61B | -1.64B | -1.86B | -1.47B | -615.89M |
| Financing Cash Flow | -169.00M | -447.73M | -749.66M | -812.33M | -565.13M | -374.51M |
Balaji Amines Limited Technical Analysis
Positive
1090.80
Price Trends
1072.37
Positive
1109.95
Positive
1321.96
Negative
Market Momentum
16.13
Negative
60.85
Neutral
93.31
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Positive. The current price of 1090.8 is above the 20-day moving average (MA) of 1057.51, above the 50-day MA of 1072.37, and below the 200-day MA of 1321.96, indicating a neutral trend. The MACD of 16.13 indicates Negative momentum. The RSI at 60.85 is Neutral, neither overbought nor oversold. The STOCH value of 93.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BALAMINES.
Balaji Amines Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹40.51B | 29.53 | ― | 0.97% | -5.17% | -22.34% | |
64 Neutral | ₹152.88B | 76.50 | ― | 0.06% | 66.49% | 112.13% | |
64 Neutral | ₹28.59B | 24.59 | ― | 0.09% | 16.09% | 1.02% | |
62 Neutral | ₹75.52B | 48.28 | ― | 0.62% | -0.48% | 1.20% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹43.08B | 211.46 | ― | 0.09% | 5.66% | -60.04% | |
46 Neutral | ₹7.05B | -2,425.33 | ― | 1.07% | -19.76% | -92.63% |
* Basic Materials Sector Average
IN:BALAMINES
Balaji Amines Limited
1,250.20
-32.33
-2.52%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,476.55
-309.98
-17.35%
IN:ANURAS
Anupam Rasayan India Ltd.
1,342.80
485.31
56.60%
IN:FAIRCHEMOR
Fairchem Organics Ltd
559.65
-299.75
-34.88%
IN:NEOGEN
Neogen Chemicals Ltd.
1,632.85
56.11
3.56%
IN:ROSSARI
Rossari Biotech Ltd
516.20
-174.73
-25.29%
Balaji Amines Limited Corporate Events
Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares
Mar 5, 2026
Balaji Amines Limited has announced that it has published newspaper advertisements in The Indian Express and Lokmat regarding a special window for the transfer and dematerialisation of physical shares. The move reflects the company’s ongoing...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.